CClinicalTrials.gg
CompletedNCT02481986Updated Dec 9, 2021Results posted

Asthma Action at Erie Trial

A Phase 3 interventional study of Community Health Worker and Certified asthma educator in Asthma and Children, sponsored by University of Illinois at Chicago. Completed at 1 site in United States. Open to participants aged 5 Years to 16 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-12-09.

Sponsored by University of Illinois at Chicago · Phase 3, Interventional, and Treatment

Phase
Phase 3
Study type
Interventional
Enrollment
223
Allocation
Randomized
Ages
5 Years to 16 Years
Sex
All
01

Study summary

The Asthma Action at Erie Trial compares the current best practice in asthma self-management education (certified asthma educator services) to an integrated community health worker (CHW) home intervention in which the real-life challenges of patients and the health care system are taken fully into account. This trial will provide clarity as to the expected effect size, cost savings, and resources needed to integrate asthma CHWs into clinical practice.

Read the detailed description

The Asthma Action at Erie Trial will test the ability of a community health worker (CHW) intervention with three important modifications to achieve asthma control in high-risk children. These modifications are: 1) CHWs will be integrated into both the clinical and the home setting, 2) A system for directly addressing mental health and psychosocial barriers will be provided, and 3) Participants will be provided only materials and equipment for trigger remediation that are supported by the current medical reimbursement system. To test this intervention, a two-arm behavioral randomized controlled trial (N=220) will be conducted in partnership with a federally-qualified health center (FQHC) serving a low income, minority population that is at high-risk for significant asthma morbidity. The intervention arm will receive an integrated CHW home intervention for pediatric asthma education. The comparison arm will received clinic-based certified asthma educator (AE-C) services. Primary Aim 1 is to assess the efficacy of the integrated CHW home asthma intervention, relative to clinic-based AE-C education over 12-months, as demonstrated by asthma control. Specific Aim 2 is to assess maintenance of intervention efficacy, as demonstrated by asthma control at 18 and 24 months after randomization. Specific Aim 3 is to determine the cost-effectiveness at 12-months of CHW and AE-C intervention delivery, and additional costs or savings related to asthma exacerbations at 12- and 24-months. Specific Aim 4 is to assess the efficacy of the integrated CHW home asthma intervention relative to clinic-based AE-C education, as demonstrated by asthma control, among those experiencing depression, stress, and/or a post-traumatic stress disorder.

02

Conditions studied

  • Asthma
  • Children

Browse trials for

03

In context

Asthma

3,921 studies on the registry are indexed under Asthma; 507 are open to participants now.

This study's enrollment of 223 is above the median of 83 across 2,752 interventional studies indexed under Asthma.

Browse Asthma studies →

Lead sponsor

University of Illinois at Chicago is the lead sponsor of 515 studies on the registry; 133 are open to participants now.

Of its 31 completed or terminated interventional studies of FDA-regulated products, 18 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Child is a patient at Erie Family Health Center
  • Child is age 5-16 at the start of the study
  • Child lives with the index caregiver at least 5 days out of the week
  • Child has uncontrolled asthma. This is defined as a score of 1.25 or greater on the Asthma Control Questionnaire, or report of oral corticosteroid use in the past year
  • Family has a working telephone

Exclusion criteria

Exclusion Criteria:

  • Exclusion criteria include family not fluent in English or Spanish, family lives in temporary housing such as a shelter, caregiver does not have permanent custody of child, or child has significant developmental delays or co-morbidities that would limit their ability to participate in the program.
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
223 participants (actual)

Study arms

  • Experimental
    Community health worker

    Participants in this arm will be offered 10 home visits in a 12-month period from community health workers (CHWs). Visits will cover a core asthma curriculum and provide social support.

    Behavioral: Community Health Worker

  • Active comparator
    Certified asthma educator

    Participants in this arm will be offered 2 education sessions with a certified asthma educator in the clinic at start of the study and again at 6-months. These sessions will be followed by a telephone call from the certified asthma educator several weeks after the sessions.

    Behavioral: Certified asthma educator

Interventions

  • BehavioralCommunity Health Worker

    A community health worker is para-professional who performs education, case management, and social support.

  • BehavioralCertified asthma educator

    A certified asthma educator has is certified and performs asthma education.

06

What researchers measure

Primary outcomes

  1. Asthma Control Test/Childhood Asthma Control Test at 12-months

    Asthma Control Test (12 years or older) or Childhood Asthma Control Test (under 12 years old) minimum 5, maximum 27, higher score means better asthma control

    Time frame: assessed 12-months from baseline, assessed over past 4 weeks

  2. Activity Limitation at 12-months

    Days of activity limitation over past 14 days minimum 0, maximum 14, higher means worse asthma control

    Time frame: assessed 12-months after baseline, assessed over past 14 days

Secondary outcomes

  1. Asthma Control Questionnaire at 12-months

    Asthma Control Questionnaire minimum 0, maximum 6, higher score means worse asthma control

    Time frame: assessed 12-months after baseline, prior week assessed

  2. Health Care Utilization at 12-months

    Any ED visits or hospitalizations for asthma (each ED visit or hospitalization is a single event, ED visits that transition into hospitalizations are coded as one event)

    Time frame: assessed 12-months after baseline, assessed from baseline to 12-months

  3. Costs of Intervention Delivery

    This measure is the total dollars spent to deliver the intervention by arm. Costs include CHW and AE-C salaries, supervision, training costs, and intervention materials that resulted in 84 AE-visits and 722 CHW visits.

    Time frame: assessed 12-months from baseline, assessed from baseline to 12-months

07

Results

Posted Dec 9, 2021

Participant flow

Participant flow — Overall Study
MilestoneCommunity Health WorkerCertified Asthma Educator
Started108115
Completed103106
Not completed59

Outcome measures

PrimaryAsthma Control Test/Childhood Asthma Control Test at 12-months

Asthma Control Test (12 years or older) or Childhood Asthma Control Test (under 12 years old) minimum 5, maximum 27, higher score means better asthma control

Time frame:
assessed 12-months from baseline, assessed over past 4 weeks
Reported as:
Least squares mean · score on a scale
Asthma Control Test/Childhood Asthma Control Test at 12-months
score on a scaleCommunity Health WorkerCertified Asthma Educator
Asthma Control Test/Childhood Asthma Control Test at 12-months21.23 (19.82 to 22.63)20.58 (19.31 to 21.85)
PrimaryActivity Limitation at 12-months

Days of activity limitation over past 14 days minimum 0, maximum 14, higher means worse asthma control

Time frame:
assessed 12-months after baseline, assessed over past 14 days
Reported as:
Least squares mean · ratio of days
Activity Limitation at 12-months
ratio of daysCommunity Health WorkerCertified Asthma Educator
Activity Limitation at 12-months0.42 (0.04 to 0.80)0.88 (0.52 to 1.23)
SecondaryAsthma Control Questionnaire at 12-months

Asthma Control Questionnaire minimum 0, maximum 6, higher score means worse asthma control

Time frame:
assessed 12-months after baseline, prior week assessed
Reported as:
Least squares mean · score on a scale
Asthma Control Questionnaire at 12-months
score on a scaleCommunity Health WorkerCertified Asthma Educator
Asthma Control Questionnaire at 12-months0.80 (0.57 to 1.04)0.88 (0.66 to 1.09)
SecondaryHealth Care Utilization at 12-months

Any ED visits or hospitalizations for asthma (each ED visit or hospitalization is a single event, ED visits that transition into hospitalizations are coded as one event)

Time frame:
assessed 12-months after baseline, assessed from baseline to 12-months
Reported as:
Least squares mean · events
Health Care Utilization at 12-months
eventsCommunity Health WorkerCertified Asthma Educator
Health Care Utilization at 12-months0.11 (0.07 to 0.18)0.20 (0.13 to 0.28)
SecondaryCosts of Intervention Delivery

This measure is the total dollars spent to deliver the intervention by arm. Costs include CHW and AE-C salaries, supervision, training costs, and intervention materials that resulted in 84 AE-visits and 722 CHW visits.

Time frame:
assessed 12-months from baseline, assessed from baseline to 12-months
Reported as:
Number · dollars spent per arm on intervention
Costs of Intervention Delivery
dollars spent per arm on interventionCommunity Health WorkerCertified Asthma Educator
Costs of Intervention Delivery5339011373

Adverse events

Collected over 24 months per participant. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Community Health Worker0/108 (0%)0/108 (0%)0/108 (0%)
Certified Asthma Educator0/115 (0%)0/115 (0%)0/115 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Community Health WorkerCertified Asthma EducatorTotal
<=18 years108115223
Between 18 and 65 years000
>=65 years000
Age, Continuous
Age, Continuous(years)Community Health WorkerCertified Asthma EducatorTotal
Mean9.3 ± 2.99.5 ± 3.29.4 ± 3.0
Sex: Female, Male
Sex: Female, Male(Participants)Community Health WorkerCertified Asthma EducatorTotal
Female465298
Male6263125
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Community Health WorkerCertified Asthma EducatorTotal
Hispanic ethnicity child9298190
Not Hispanic ethnicity child161733
Black race child182139
Not Black race child9093183
Region of Enrollment
Region of Enrollment(participants)Community Health WorkerCertified Asthma EducatorTotal
United States108115223
08

Study locations

1 site
  • Erie Family Health Center
    Chicago, Illinois 60622, United States
09

References and documents

Publications

  • Weinstein SM, Pugach O, Rosales G, Mosnaim GS, Orozco K, Pappalardo AA, Martin MA. Psychosocial Moderators and Outcomes of a Randomized Effectiveness Trial for Child Asthma. J Pediatr Psychol. 2021 Jul 20;46(6):673-687. doi: 10.1093/jpepsy/jsab011. PubMed 33616185 ↗
  • Weinstein SM, Pugach O, Rosales G, Mosnaim GS, Walton SM, Martin MA. Family Chaos and Asthma Control. Pediatrics. 2019 Aug;144(2):e20182758. doi: 10.1542/peds.2018-2758. Epub 2019 Jul 9. PubMed 31289192 ↗
  • Mosnaim GS, Weinstein SM, Pugach O, Rosales G, Roy A, Walton S, Martin MA. Design and baseline characteristics of a low-income urban cohort of children with asthma: The Asthma Action at Erie Trial. Contemp Clin Trials. 2019 Apr;79:55-65. doi: 10.1016/j.cct.2019.02.006. Epub 2019 Feb 14. PubMed 30772471 ↗

Study documents

  • Protocol and statistical analysis plan · Feb 28, 2018

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 9, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02481986
Lead sponsor
University of Illinois at Chicago
Collaborators
Erie Family Health Center, Rush University Medical Center, National Heart, Lung, and Blood Institute (NHLBI)
Responsible party
Molly A. Martin (Associate Professor, University of Illinois at Chicago) — Principal investigator
First posted
Jun 25, 2015
Start date
Apr 1, 2015
Primary completion
Mar 31, 2020
Completion
Mar 31, 2021
Results posted
Dec 9, 2021
Last update
Dec 9, 2021

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion